Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Bolt Biotherapeutics, Inc. (BOLT) had Debt to Capital Ratio of 0.43 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$7.70M |
|
$-33.38M |
|
-- |
|
$7.70M |
|
$43.81M |
|
$-36.11M |
|
$2.74M |
|
$-33.38M |
|
$-33.38M |
|
$-33.38M |
|
$-33.38M |
|
$-33.38M |
|
$-33.38M |
|
$-36.11M |
|
$-35.49M |
|
1.87M |
|
1.87M |
|
$-17.85 |
|
$-17.85 |
|
| Balance Sheet Financials | |
$30.26M |
|
$1.25M |
|
$26.49M |
|
$56.75M |
|
$8.44M |
|
$20.13M |
|
$21.81M |
|
$30.24M |
|
$26.50M |
|
$26.50M |
|
$26.50M |
|
1.92M |
|
| Cash Flow Statement Financials | |
$-39.85M |
|
$44.30M |
|
$0.02M |
|
$8.97M |
|
$13.44M |
|
$4.47M |
|
$2.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.59 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.43 |
0.76 |
|
100.00% |
|
-469.30% |
|
-469.30% |
|
-461.23% |
|
-433.74% |
|
-433.74% |
|
$-38.96M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
-- |
|
-- |
|
-- |
|
-125.92% |
|
-125.92% |
|
-58.81% |
|
-71.57% |
|
$13.80 |
|
$-20.83 |
|
$-21.31 |
|